- Ages
- 18 Years - 75 Years
- Sexes
- All
Clinical trials
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis -
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF) - Investigator
- Sandeep Grover
- Ages
- N/A
- Sexes
- All
-
SWAP 8 - Investigator
- Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
SWAP 9 - Investigator
- Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
TAILOR BLEED - Investigator
- Dominick J Angiolillo
- Ages
- N/A
- Sexes
- All
-
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study - Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
The Bridging Antiplatelet Therapy with Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens - Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All